SOX2 regulates apoptosis through MAP4K4-Survivin signaling pathway in human lung cancer cells

Sox2 protects neural stem cells from apoptosis via up-regulating survivin expression

(2013) Ruopeng Feng et al.   BIOCHEMICAL JOURNAL

SOX2 promotes tumor metastasis by stimulating epithelial-to-mesenchymal transition via regulation of WNT/β-catenin signal network

(2013) Xuefei Li et al.   CANCER LETTERS

Expression of Sox2 and Oct4 and Their Clinical Significance in Human Non-Small-Cell Lung Cancer

(2012) Xinxin Li et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Expression and prognostic significance of MAP4K4 in lung adenocarcinoma

(2012) Mei-Hua Qiu et al.   PATHOLOGY RESEARCH AND PRACTICE

Prognostic Value of Survivin in Patients with Non-Small Cell Lung Carcinoma: A Systematic Review with Meta-Analysis

(2012) Lou Qian Zhang et al.   PLoS One

SOX2 Gene Regulates the Transcriptional Network of Oncogenes and Affects Tumorigenesis of Human Lung Cancer Cells

(2012) Si Chen et al.   PLoS One

Respiratory Syncytial Virus Matrix Protein Induces Lung Epithelial Cell Cycle Arrest through a p53 Dependent Pathway

(2012) Tao Bian et al.   PLoS One

The antiapoptotic gene survivin is highly expressed in human chondrosarcoma and promotes drug resistance in chondrosarcoma cells in vitro

(2011) Philipp Lechler et al.   BMC CANCER

Downregulation of transcription factor SOX2 in cancer stem cells suppresses growth and metastasis of lung cancer

(2011) R Xiang et al.   BRITISH JOURNAL OF CANCER

ShRNA-Targeted MAP4K4 Inhibits Hepatocellular Carcinoma Growth

(2011) A.-W. Liu et al.   CLINICAL CANCER RESEARCH

Survivin expression and targeting in breast cancer

(2011) Kumkum Jha et al.   SURGICAL ONCOLOGY-OXFORD

SOX2 promotes tumorigenesis and increases the anti-apoptotic property of human prostate cancer cell

(2011) X. Jia et al.   Journal of Molecular Cell Biology

TNF-α respecifies human mesenchymal stem cells to a neural fate and promotes migration toward experimental glioma

(2010) V Egea et al.   CELL DEATH AND DIFFERENTIATION

SOX2 Is an Oncogene Activated by Recurrent 3q26.3 Amplifications in Human Lung Squamous Cell Carcinomas

(2010) Thomas Hussenet et al.   PLoS One

Correlation of CD133, OCT4, and SOX2 in Rectal Cancer and Their Association with Distant Recurrence After Chemoradiotherapy

(2009) Susumu Saigusa et al.   ANNALS OF SURGICAL ONCOLOGY

Silencing Mitogen-activated Protein 4 Kinase 4 (MAP4K4) Protects Beta Cells from Tumor Necrosis Factor-α-induced Decrease of IRS-2 and Inhibition of Glucose-stimulated Insulin Secretion

(2009) Karim Bouzakri et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Runx2 regulates survivin expression in prostate cancer cells

(2009) Minyoung Lim et al.   LABORATORY INVESTIGATION

Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation

(2009) Myriam Aouadi et al.   NATURE

SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas

(2009) Adam J Bass et al.   NATURE GENETICS

Expression of MAP4K4 Is Associated with Worse Prognosis in Patients with Stage II Pancreatic Ductal Adenocarcinoma

(2008) J. J. Liang et al.   CLINICAL CANCER RESEARCH

The Molecular Mechanism Governing the Oncogenic Potential of SOX2 in Breast Cancer

(2008) Yupeng Chen et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Transcriptional regulation of survivin by c-Myc in BCR/ABL-transformed cells: implications in anti-leukaemic strategy

(2008) Zhi Hong Fang et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE